VEGFC and glioblastoma: In particular, in contrast with PV-FP and PV-O subtype, PV-T glioblastomas were characterized by a high expression of the mesenchymal marker VEGFC and the proneural and CSC markers NOTCH1 and PROM1 that could be potential targets for specific therapies.